New sustained release oral formulations

Details New sustained release oral formulations New sustained release oral formulations

A - Human Necessities

61

K

A61K 31/27 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 9/36 (2006.01) A61K 9/50 (2006.01) A61P 25/28 (2006.01) A61K 9/28 (2006.01)

Patent

CA 2342340

Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigmine, in a time-controlled manner.

Cette invention a trait à une composition pharmaceutique à même de libérer une dose efficace du point de vue thérapeutique d'un agent actif, de la rivastigmine par exemple, et ce, d'une façon régulée dans le temps.

Affiliated with

Also associated with

Rating

New sustained release oral formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New sustained release oral formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New sustained release oral formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1906993